Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection (Q33215051)
scientific article published in January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection |
scientific article published in January 2005 |
Statements
1 reference
Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection (English)
1 reference
Ansgar Schuffenhauer
1 reference
Edgar Jacoby
1 reference
Maxim Popov
1 reference
Kamal Azzaoui
1 reference
Benjamin Havill
1 reference
Ulrich Schopfer
1 reference
Caroline Engeloch
1 reference
Jaroslav Stanek
1 reference
Pierre Acklin
1 reference
Pascal Rigollier
1 reference
Friederike Stoll
1 reference
Guido Koch
1 reference
Peter Meier
1 reference
David Orain
1 reference
Rudolph Giger
1 reference
Jürgen Hinrichs
1 reference
Karine Malagu
1 reference
Jürg Zimmermann
1 reference
Hans-Joerg Roth
1 reference
1 January 2005
1 reference
1 reference
397-411
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference